Senior Management Team

Become a leading global bio pharmaceutical company
for the development of novel drugs

Dr. Shui On LEUNG

Founder, Chairman of our Board, Executive Director, Chief Executive Officer

Dr. Leung, our founder, also serves as our chief executive officer. He is a pragmatic entrepreneur with extensive knowledge of the entire industry chain that, we believe, cannot be emulated by many. Dr. Leung’s vision of the industry drives the growth of our Company and his all-round experience and expertise enable him to oversee and guide every aspect of our development.

Mr. Jing QIANG

Executive Director, President

Mr. Qiang has served as the president of the Company since March 2018 and is primarily responsible for strategic planning and investments. Mr. Qiang has over nine years of experience in the field of medicine and healthcare related research and investment, and was qualified as a Chartered Financial Analyst (CFA) by the CFA Institute in September 2011 and as a Financial Risk Manager (FRM) by the Global Association of Risk Professionals in April 2009. Mr. Qiang has been appointed as an executive Director of the Company.

Mr. Jianping HUA

Chief Financial Officer

Mr. Jianping Hua, our chief financial officer, is responsible for our overall financial management and operation, financing and investment activities. Mr. Hua has more than 14 years of experience in the financial and investment sector.

Mr. Gang CHEN

Chief Medical Officer

Mr. Gang Chen, our chief medical officer, is responsible for the overall management of our clinical R&D, including clinical development, operation and regulatory affairs. Mr. Chen has over 17 years of experience in the field of medical science and clinical research.

Dr. Ming Hon YAU

Director (Downstream Process Development)

Dr. Ming Hon YAU (游明翰), joined our Company in January 2012 as a research project manager (research and development), subsequently as an associate director (research and development) of our Company from January 2015 to March 2019 and has served as a managing director (downstream process) of our Company since April 2019. Dr. Yau is primarily responsible for supervising downstream purification process development, overseeing manufacturing operations of antibody products, establishing associated good manufacturing practice (GMP) system, and supervising operation compliance and planning of Suzhou production base.

Dr. Kwan Yin SIU

Associate Director (Manufacturing/Upstream processing group)

Dr. Kwan Yin SIU (蕭君言), joined our Company in November 2011 as a research scientist, subsequently as principal senior scientist (bioprocess) from January 2015 to March 2019, and has served as an associate director (manufacturing/upstream processing group) of our Company since April 2019. Dr. Siu is primarily responsible for supervising upstream production and research process for culture media preparation, cell culture and bioreactor operations.

Dr. Ka Wa Benny CHEUNG

Principal Senior Scientist

English: Dr. Ka Wa Benny CHEUNG (張嘉華), joined our Company in January 2010 as a research scientist and has served as a principal senior scientist of our Company since January 2015. Dr. Cheung is primarily responsible for managing R&D laboratory in Hong Kong.